Effectiveness and safety of COVID-19 vaccines in healthcare workers in Buenos Aires City, Argentina.
Universidad Nacional de Córdoba.
Introduction: COVID-19 vaccination aids pandemic limitation. In Argentina, three vaccines are approved, and healthcare workers are priorized (HCWs). The aim was to determine the effectiveness of COVID-19 vaccines, analyzing change in Immunoglobulin G levels and the incidence of new COVID-19 cases up to 12 months after the second dose.
Methods: Prospective cohort of HCWs between March 2021- 2022. COVIDAR IgG test was used to measure antibodies. A mixed-effects model was employed to compare the levels of immunoglobulin G at different time points, Kaplan Meier was used to estimate incident COVID-19 cases.
Results: 82 participants were included Adverse events were frequent but mild. All participant showed positive antibody at 12 months. Antibodies levels showed an increase one year after 2nd dose. Sinopharm took a long time to yield positive results. More than half of the people had mild COVID-19 disease.
Conclusion: COVID-19 vaccines are safe and effective.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:81 |
|---|---|
| Enthalten in: |
Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) - 81(2024), 1 vom: 27. März, Seite 115-127 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Efectividad y seguridad de las vacunas contra la Covid-19 en trabajadores de la salud en la Ciudad de Buenos Aires, Argentina |
|---|
| Beteiligte Personen: |
Pagotto, Vanina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 Vaccines |
|---|
| Anmerkungen: |
Date Completed 29.03.2024 Date Revised 04.04.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.31053/1853.0605.v81.n1.41155 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370266447 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370266447 | ||
| 003 | DE-627 | ||
| 005 | 20240404235207.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240329s2024 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.31053/1853.0605.v81.n1.41155 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1364.xml |
| 035 | |a (DE-627)NLM370266447 | ||
| 035 | |a (NLM)38537101 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Pagotto, Vanina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effectiveness and safety of COVID-19 vaccines in healthcare workers in Buenos Aires City, Argentina. |
| 246 | 3 | 3 | |a Efectividad y seguridad de las vacunas contra la Covid-19 en trabajadores de la salud en la Ciudad de Buenos Aires, Argentina |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.03.2024 | ||
| 500 | |a Date Revised 04.04.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Universidad Nacional de Córdoba | ||
| 520 | |a Introduction: COVID-19 vaccination aids pandemic limitation. In Argentina, three vaccines are approved, and healthcare workers are priorized (HCWs). The aim was to determine the effectiveness of COVID-19 vaccines, analyzing change in Immunoglobulin G levels and the incidence of new COVID-19 cases up to 12 months after the second dose | ||
| 520 | |a Methods: Prospective cohort of HCWs between March 2021- 2022. COVIDAR IgG test was used to measure antibodies. A mixed-effects model was employed to compare the levels of immunoglobulin G at different time points, Kaplan Meier was used to estimate incident COVID-19 cases | ||
| 520 | |a Results: 82 participants were included Adverse events were frequent but mild. All participant showed positive antibody at 12 months. Antibodies levels showed an increase one year after 2nd dose. Sinopharm took a long time to yield positive results. More than half of the people had mild COVID-19 disease | ||
| 520 | |a Conclusion: COVID-19 vaccines are safe and effective | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 serological testing | |
| 650 | 4 | |a health personnel | |
| 650 | 4 | |a COVID-19 vaccines | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Seoane, Facundo |e verfasserin |4 aut | |
| 700 | 1 | |a Arrigo, Diego |e verfasserin |4 aut | |
| 700 | 1 | |a Ardiles, Victoria |e verfasserin |4 aut | |
| 700 | 1 | |a Asprea, Valeria |e verfasserin |4 aut | |
| 700 | 1 | |a De Florio, Florencia |e verfasserin |4 aut | |
| 700 | 1 | |a Ferloni, Analia |e verfasserin |4 aut | |
| 700 | 1 | |a Aliperti, Valeria |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) |d 1994 |g 81(2024), 1 vom: 27. März, Seite 115-127 |w (DE-627)NLM000465275 |x 1853-0605 |7 nnns |
| 773 | 1 | 8 | |g volume:81 |g year:2024 |g number:1 |g day:27 |g month:03 |g pages:115-127 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.31053/1853.0605.v81.n1.41155 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 81 |j 2024 |e 1 |b 27 |c 03 |h 115-127 | ||